Article

Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus

2021-12-15

Abstract excerpt

COVID-19 and influenza are both highly contagious respiratory diseases with a wide range of severe symptoms and cause great disease burdens globally. It has become very urgent and important to develop a bivalent vaccine that is able to target these two infectious diseases simultaneously. In this study, we generated three attenuated replicating recombinant VSV (rVSV) vaccine candidates. These rVSV-based vaccines co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e0cfed10-e626-54e6-9c84-bfdd715b51ec
DOI: 10.1101/2021.12.14.472657

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza VirusDOI 10.1101/2021.12.14.472657Read

Single-shot rAAV5-based Vaccine Provides Long-term Protective Immunity against SARS-CoV-2 and Its VariantsSemantic proximity Read

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in miceSemantic proximity Read

Single-dose respiratory mucosal delivery of next-generation viral-vectored COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2Semantic proximity Read

Development of attenuated coxsackievirus B3 vectored intranasal pre-emptive pan-coronavirus vaccineSemantic proximity Read

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum ProtectionSemantic proximity Read

Development of a Recombinant Single-Cycle Influenza Viral Vector as an Intranasal Vaccine against SARS-CoV-2 and SARS-like BetacoronavirusesSemantic proximity Read

A 10-valent composite mRNA vaccine against both influenza and COVID-19Semantic proximity Read

A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaquesSemantic proximity Read

Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platformSemantic proximity Read

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoVSemantic proximity Read

Optimization of single dose VSV-based COVID-19 vaccination in hamstersSemantic proximity Read

Development of an RBD-Fc fusion vaccine for COVID-19Semantic proximity Read